Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,242

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,844

Class I recallsReasonable probability of serious health consequences

24,383

Class II recallsTemporary or medically reversible health consequences

2,897

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,084 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/krasnyi-oktyabr-inc-recalls-starfish-seafood-trio-because-possible-health-riskPublished October 9, 2026

Most affected stateHawaii 200 recalls mention this state

State: GA ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 10, 2026 ET

Summary (Year to date)

1,739 recalls have been announced year to date.
Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (300).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,383
Class I	9,844
Class III	2,897
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,383
Class I	9,844
Class III	2,897
Not Yet Classified	2

FDA Recall TerminatedTerminated: April 19, 2017Historical recordClass II

Methylcobalamin and Folic Acid Injectable Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746

by Axium Healthcare Pharmacy dba Balanced Solutions Compounding

Reason: Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Published: May 1, 2013
Distribution: CO, GA, MI, and Puerto Rico

View recall →

FDA Recall TerminatedTerminated: April 19, 2017Historical recordClass II

Cyanocobalamin (CMP) Injectable Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746

by Axium Healthcare Pharmacy dba Balanced Solutions Compounding

Reason: Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Published: May 1, 2013
Distribution: CO, GA, MI, and Puerto Rico

View recall →

FDA Recall TerminatedTerminated: April 19, 2017Historical recordClass II

Triamcinolone Hexacetonide Injectable Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746

by Axium Healthcare Pharmacy dba Balanced Solutions Compounding

Reason: Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Published: May 1, 2013
Distribution: CO, GA, MI, and Puerto Rico

View recall →

FDA Recall TerminatedTerminated: April 19, 2017Historical recordClass II

Betamethasone Injectable Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746

by Axium Healthcare Pharmacy dba Balanced Solutions Compounding

Reason: Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Published: May 1, 2013
Distribution: CO, GA, MI, and Puerto Rico

View recall →

FDA Recall TerminatedTerminated: April 19, 2017Historical recordClass II

Sodium Tetradecyl Sulfate Injectable Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746

by Axium Healthcare Pharmacy dba Balanced Solutions Compounding

Reason: Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Published: May 1, 2013
Distribution: CO, GA, MI, and Puerto Rico

View recall →

FDA Recall TerminatedTerminated: April 19, 2017Historical recordClass II

Methylprednisolone Acetate injectable Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746

by Axium Healthcare Pharmacy dba Balanced Solutions Compounding

Reason: Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Published: May 1, 2013
Distribution: CO, GA, MI, and Puerto Rico

View recall →

FDA Recall TerminatedTerminated: April 19, 2017Historical recordClass II

TriMix Standartd (PGE Stock Sol'n) Injectable Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746

by Axium Healthcare Pharmacy dba Balanced Solutions Compounding

Reason: Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Published: May 1, 2013
Distribution: CO, GA, MI, and Puerto Rico

View recall →

FDA Recall TerminatedTerminated: December 5, 2013Historical recordClass III

Lisinopril Tablets, USP 10 mg, Rx only, 1000 count bottles, Manufactured for: Mylan Pharmaceuticals Inc ,Morgantown, WV 26505 U.S.A. Made in India; NDC 0378-20740-10

by Mylan Pharmaceuticals Inc.

Reason: Tablets/Capsules Imprinted With Wrong ID: Pharmaceuticals are imprinted with an incorrect identifier code on the embossed tablets..
Published: May 1, 2013
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 26, 2014Historical recordClass II

Amoxicillin Capsules USP 500 mg, Manufactured in Austria by Sandoz GmbH for Sandoz Inc., Princeton, NJ 08540, Rx only. Manufactured in 500 ct (NDC 0781-2613-05) and 30 ct (NDC 0781-2613-31) bottles.

by Sandoz Incorporated

Reason: Presence of Foreign Substance, Sandoz is recalling certain lots of Amoxicillin Capsules, USP 500 mg due to potential contamination with fragments of stainless steel wire mesh.
Published: May 1, 2013
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: November 14, 2013Historical recordClass I

WOW, Health Enterprises, Dietary Supplement, 30 Caplets, Distributed by: Health Enterprises, 1002 E 5th St., Canton, SD 57013. Manufactured by Riger Natural, S. A. Mexico.

by Brower Enterprises Inc

Reason: Marketed without an Approved NDA/ANDA: Brower Enterprises Inc., is recalling its WOW Health Enterprises Dietary Supplement, because it contains undeclared drug ingredients making it an unapproved drug. FDA sample analysis has found the product to contain methocarbamol, dexamethasone, and diclofenac.
Published: May 1, 2013
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: April 19, 2017Historical recordClass II

Trimix Customs Injectable Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746

by Axium Healthcare Pharmacy dba Balanced Solutions Compounding

Reason: Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Published: May 1, 2013
Distribution: CO, GA, MI, and Puerto Rico

View recall →

FDA Recall TerminatedTerminated: June 5, 2013Historical recordClass I

Actra-SX 500 Capsules, Maximum Strength, Energizer, 500 mg, 5 count package, Body Basics, Canoga Park, CA

by Body Basics Inc

Reason: Marketed without an Approved NDA/ANDA; product contains sildenafil, an active ingredient in a FDA approved product for the treatment of Erectile Dysfunction
Published: April 24, 2013
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 11, 2013Historical recordClass III

Suprax (cefixime for oral suspension) USP, 100 mg/5 mL, 50 mL bottles (when reconstituted), Manufactured for Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, MD 21202, Manufactured by Lupin Limited Mumbai 400 058 India, NDC 68180-202-03.

by Lupin Pharmaceuticals Inc.

Reason: Discoloration; Product may not meet specifications for color description once reconstituted.
Published: April 24, 2013
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2015Historical recordClass I

Lactated Ringer's and 5% Dextrose Injection, USP, 1000 mL flexible containers, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7929-09.

by Hospira Inc.

Reason: Non-Sterility: One confirmed customer report that product contained spore-like particulates, consistent with mold.
Published: April 24, 2013
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2015Historical recordClass I

Lactated Ringer's and 5% Dextrose Injection, USP, 1000 mL flexible container, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA; NDC 0409-7929-09.

by Hospira Inc.

Reason: Non-Sterility: Confirmed customer complaint of product contaminated with mold.
Published: April 24, 2013
Distribution: Nationwide

View recall →

FDA Recall CompletedHistorical recordClass II

Levoxyl (levothyroxine sodium) tablets, USP 200 mcg, packaged in a) 100-count bottles (NDC 60793-860-01) and b) 1000-count bottles ( NDC 60793-860-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.

by Pfizer Inc.

Reason: Chemical contamination: emission of strong odor after package was opened.
Published: April 24, 2013
Distribution: Nationwide

View recall →

FDA Recall CompletedHistorical recordClass II

Levoxyl (levothyroxine sodium) tablets, USP 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and b) 1000-count bottles ( NDC 60793-859-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.

by Pfizer Inc.

Reason: Chemical contamination: emission of strong odor after package was opened.
Published: April 24, 2013
Distribution: Nationwide

View recall →

FDA Recall CompletedHistorical recordClass II

Levoxyl (levothyroxine sodium) tablets, USP 150 mcg, packaged in a) 100-count bottles (NDC 60793-858-01) and b) 1000-count bottles ( NDC 60793-858-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.

by Pfizer Inc.

Reason: Chemical contamination: emission of strong odor after package was opened.
Published: April 24, 2013
Distribution: Nationwide

View recall →

FDA Recall CompletedHistorical recordClass II

Levoxyl (levothyroxine sodium) tablets, USP 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and b) 1000-count bottles ( NDC 60793-857-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.

by Pfizer Inc.

Reason: Chemical contamination: emission of strong odor after package was opened.
Published: April 24, 2013
Distribution: Nationwide

View recall →

FDA Recall CompletedHistorical recordClass II

Levoxyl (levothyroxine sodium) tablets, USP 125 mcg, packaged in a) 100-count bottles (NDC 60793-856-01) and b) 1000-count bottles ( NDC 60793-856-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.

by Pfizer Inc.

Reason: Chemical contamination: emission of strong odor after package was opened
Published: April 24, 2013
Distribution: Nationwide

View recall →

Data last updated: October 10, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.